Xact Kapitalforvaltning’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-4,400	Closed	-$268K	–	1323
2019 Q4	$268K	Buy	+4,400	New	+$268K	﹤0.01%	1285
2019 Q3	–	Sell	-4,400	Closed	-$207K	–	1431
2019 Q2	$207K	Buy	+4,400	New	+$207K	﹤0.01%	1376